千红制药: 关于实际控制人的一致行动人增持股份计划实施完成暨增持股份触及1%整数倍的公告

Core Viewpoint - The announcement details the completion of a shareholding increase plan by Wang Ke, an action-in-concert party of the actual controller Wang Yaofang, reflecting confidence in the company's future development and long-term investment value [1][2]. Group 1: Shareholding Increase Details - Wang Ke has increased his shareholding by 9,600,000 shares from June 20, 2025, and an additional 12,400,000 shares from June 24 to 25, 2025, totaling 22,000,000 shares [1][3]. - After the increase, Wang Ke and Wang Yaofang collectively hold 340,811,600 shares, representing 26.63% of the total share capital [1][2]. Group 2: Shareholding Structure Before and After Increase - Before the increase, Wang Ke held 7,300,960 shares (6.67%), and after the increase, he holds 8,540,960 shares (6.67%) [2][3]. - Wang Yaofang's shareholding remains unchanged at 25,540,200 shares (19.96%) before and after the increase [2][3]. Group 3: Compliance and Regulations - The shareholding increase was conducted in accordance with relevant regulations, including the Securities Law and the Management Measures for the Acquisition of Listed Companies [3][4]. - Wang Ke has committed to not reducing his shareholding during the increase period and will complete the plan within the stipulated timeframe [3][4].